Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Innocenti

Showing results (51-60 of 186) with videos related to

Pageof 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphismWanqing Liu, Federico Innocenti, Peixian Chen, et al.
Pharmacogenetics and Genomics|May 3, 2005
Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genesFederico Innocenti, Wanqing Liu, Peixian Chen, et al.
JCO Oncology Practice|November 16, 2020
All You Need to Know About <i>DPYD</i> Genetic Testing for Patients Treated With Fluorouracil and Capecitabine: A Practitioner-Friendly GuideFederico Innocenti, Sarah C Mills, Hanna Sanoff, et al.
European Journal of Cancer (Oxford, England : 1990)|May 26, 2009
R(+)XK469 inhibits hydroxylation of S-warfarin by CYP2C9Wei Peng Yong, Tae Won Kim, Samir D Undevia, et al.
Pharmaceutical Research|June 19, 2002
In vitro characterization of hepatic flavopiridol metabolism using human liver microsomes and recombinant UGT enzymesJacqueline Ramírez, Lalitha Iyer, Kim Journault, et al.
International Journal of Cancer|December 10, 2002
Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patientsGiuseppe Toffoli, Antonio Russo, Federico Innocenti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2022
Acquired Genomic Alterations on First-Line Chemotherapy With Cetuximab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of the CALGB/SWOG-80405 Trial (Alliance)Kanwal Raghav, Fang-Shu Ou, Alan P Venook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecanErika Cecchin, Federico Innocenti, Mario D'Andrea, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 2007
Lack of association between common polymorphisms in UGT1A9 and gene expression and activityJacqueline Ramírez, Wanqing Liu, Snezana Mirkov, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 17, 2006
Effects of green tea compounds on irinotecan metabolismSnezana Mirkov, Bernard J Komoroski, Jacqueline Ramírez, et al.
Pageof 19

Showing results (51-60 of 186) with videos related to

Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphismWanqing Liu, Federico Innocenti, Peixian Chen, et al.
Pharmacogenetics and Genomics|May 3, 2005
Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genesFederico Innocenti, Wanqing Liu, Peixian Chen, et al.
JCO Oncology Practice|November 16, 2020
All You Need to Know About <i>DPYD</i> Genetic Testing for Patients Treated With Fluorouracil and Capecitabine: A Practitioner-Friendly GuideFederico Innocenti, Sarah C Mills, Hanna Sanoff, et al.
European Journal of Cancer (Oxford, England : 1990)|May 26, 2009
R(+)XK469 inhibits hydroxylation of S-warfarin by CYP2C9Wei Peng Yong, Tae Won Kim, Samir D Undevia, et al.
Pharmaceutical Research|June 19, 2002
In vitro characterization of hepatic flavopiridol metabolism using human liver microsomes and recombinant UGT enzymesJacqueline Ramírez, Lalitha Iyer, Kim Journault, et al.
International Journal of Cancer|December 10, 2002
Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patientsGiuseppe Toffoli, Antonio Russo, Federico Innocenti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2022
Acquired Genomic Alterations on First-Line Chemotherapy With Cetuximab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of the CALGB/SWOG-80405 Trial (Alliance)Kanwal Raghav, Fang-Shu Ou, Alan P Venook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecanErika Cecchin, Federico Innocenti, Mario D'Andrea, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 2007
Lack of association between common polymorphisms in UGT1A9 and gene expression and activityJacqueline Ramírez, Wanqing Liu, Snezana Mirkov, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 17, 2006
Effects of green tea compounds on irinotecan metabolismSnezana Mirkov, Bernard J Komoroski, Jacqueline Ramírez, et al.
Pageof 19